Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
Haemonetics (NYSE: HAE) will release third quarter fiscal 2026 results at 6:00 am ET on Thursday, February 5, 2026.
Rhea-AI Summary
Haemonetics (NYSE: HAE) will release third quarter fiscal 2026 results at 6:00 am ET on Thursday, February 5, 2026. The company will host a conference call with investors and analysts at 8:00 am ET on February 5, 2026, accessible by teleconference after registration, which provides a dial-in number and personalized PIN. A live webcast will be available on Haemonetics' investor relations website at the provided link. A replay of the conference call and webcast will be available for one year starting February 5, 2026 at 11:00 am ET. Participants are recommended to join the call 10 minutes early.
Positive
- None.
Negative
- None.
Details
News Market Reaction – HAE
In the Jan 8 session, HAE gained 1.25%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Q3 FY26 release time
- 6:00 am ET
- Planned publication time for Q3 fiscal 2026 results on February 5, 2026
- Earnings call time
- 8:00 am ET
- Scheduled Q3 FY26 conference call on February 5, 2026
- Replay availability
- 1 year
- Replay of Q3 FY26 conference call available starting February 5, 2026
- Q2 2026 net revenues
- $327.3 million
- Three months ended September 27, 2025
- Q2 2026 gross profit
- $194.7 million
- Three months ended September 27, 2025
- Q2 2026 net income
- $38.7 million
- Three months ended September 27, 2025; diluted EPS $0.81
- Operating cash flow
- $128.7 million
- Six months ended September 27, 2025
- Impairment charge
- $8.6 million
- Impairment of certain Hospital business intangibles
Historical Context
-
Announcement of CEO presentation at J.P. Morgan Healthcare Conference.
-
Second quarter fiscal 2026 results and materials posted to IR site.
-
Scheduled Q2 FY26 results date and associated conference call details.
-
First quarter fiscal 2026 financial results posted and discussed with investors.
-
Scheduled Q1 FY26 results release and follow-up conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The call can be accessed via teleconference at: Q3 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/uz42wd2z
A replay of the conference call and webcast will be available for one year beginning on February 5, 2026 at 11:00 am ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2026-results-february-5-2026-302655773.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.